Furthermore, increased CXCR4 expression on CLL cells also accounts for their resistance to spontaneous or drug-induced apoptosis, providing a protective niche for tumor cells, and making them unresponsive to conventional chemotherapy (79, 88–91). Here, CXCR4 is linked to B-cell chronic lymphocytic leukemia.